ClinicalTrials.Veeva

Menu
U

UZ Gent | Polikliniek - Reumatologie Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vericiguat
MK-6194
MK-1242-036
MK-6194-007

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

Researchers are looking for a new way to treat people with non-segmental vitiligo (NSV). The goal of this study is to learn about the safety of MK-61...

Active, not recruiting
Non-segmental Vitiligo
Biological: MK-6194
Drug: Placebo

The purpose of this study is to learn if V940 which is an individualized neoantigen therapy (INT; formerly, called messenger ribonucleic acid \[mRNA\...

Active, not recruiting
Melanoma
Biological: Pembrolizumab
Biological: V940

This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline t...

Enrolling
Left Ventricular Systolic Dysfunction
Heart Failure
Drug: Vericiguat tablet
Drug: Placebo tablet

Trial sponsors

Merck Sharp & Dohme (MSD) logo
AbbVie logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems